JFL Life Sciences Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was INR 192.4 million compared to INR 60 million a year ago. Revenue was INR 193.3 million compared to INR 60.3 million a year ago.

Net income was INR 10 million compared to INR 11.2 million a year ago. Basic earnings per share from continuing operations was INR 1.21 compared to INR 22.54 a year ago. Diluted earnings per share from continuing operations was INR 1.21 compared to INR 22.54 a year ago.